PFA the confirmation w.r.t. the non-applicability of the SEBI Circulars as mentioned in the captioned subject for the F.Y. 2024-25
Awaiting price reaction for this filing.
MPS Pharmaa Limited (formerly Advik Laboratories Limited) has confirmed to BSE and Ahmedabad Stock Exchange that it does not fall under the 'Large Corporate (LC)' category as defined under SEBI circulars dated November 26, 2018 and October 19, 2023. As per the disclosure, the company's outstanding long-term borrowing stood at Rs. 7.46 crore as on March 31, 2025, well below the Rs. 100 crore threshold required to qualify as a Large Corporate. No credit rating or fine-related details were applicable. The filing is a routine annual compliance disclosure required from listed entities.
This is a routine regulatory compliance filing with no material impact on shareholders or stock price. It simply confirms the company is exempt from mandatory incremental debt-security issuance obligations applicable to larger listed entities.